Sepsis Diagnostics Licensing and Distribution Opportunities
Diagnostics and hybridoma portfolio
The 10-minute IMIWN sTLR2 RAPID test, proprietary panel of anti-human soluble Toll-like Receptor 2 (sTLR2) hybridomas, anti-human (sTLR2) monoclonal and polyclonal antibodies, have diverse applications including sepsis and inflammation.
- Rapid sTLR2 lateral flow assay for use with serum, plasma and whole blood
- Proprietary hybridoma panel producing high affinity anti-human sTLR2 monoclonal antibodies
- Monoclonal anti-sTLR2 antibody pairs for immunoassay development
-
Polyclonal anti-human sTLR2 antibodies
The rapid test is UKCA certified in Great Britain, registered with MHRA, and available elsewhere for research use. Developed and manufactured at our ISO 13485:2016 certified laboratories in North Wales.
To discuss global licensing and distribution opportunities, please email bd@jrbiomed.com